Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Idp-121
Plasma Cell Myeloma
IDP Discovery Pharma S.L.
P1/2
CC
(45)
Ifebemtinib
Small Cell Lung Carcinoma
InxMed (Shanghai) Co., Ltd.
P1/2
CC
(45)
Ifinatamab Deruxtecan
Cancer
Merck Sharp & Dohme LLC
P1/2
CC
(45)
Ifinatamab Deruxtecan
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(45)
il15-transpresenting wt1-targeted dendritic cell vaccine
Ovarian Cancer
University Hospital, Antwerp
P1/2
CC
(45)
ilb2109
Classic Hodgkin Lymphoma
Innolake Biopharm
P1/2
CC
(45)
ilb2109
Nasopharyngeal Carcinoma
Innolake Biopharm
P1/2
CC
(45)
ilb2109
Soft Tissue Sarcoma
Innolake Biopharm
P1/2
CC
(45)
IM19 CAR-T cells
Neoplasm
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(45)
Imcy-0141
Relapsing-Remitting Multiple Sclerosis
Imcyse SA
P1/2
CC
(45)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)
B-Cell Neoplasm
BeOne Medicines
P1/2
CC
(45)
Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer
Colorectal Carcinoma
Dan Feng
P1/2
CC
(45)
Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer
Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P1/2
CC
(45)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Il2 (Interleukin 2)], Homo Sapiens Antibody; Gamma1 Heavy Chain Homo Sapiens (1-451) [Vh (Homo Sapiens Ighv1-24*01 (84.5%) -(Ighd) -Ighj4*01 (92.9%), Cdr-Imgt [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo Sapiens Ighg1*01, G1M17,1, G1V43 Ch2 A1.3, E1.2, A1 (Ch1 K120 (218) (122-219), Hinge 1-15 (220- 234), Ch2 L1.3>A (238), L1.2>E (239), (235- 344), Ch3 (345-449), Chs (450-451)) (122-451)], (224-220')-Disulfide With Kappa Light Chain Homo Sapiens (1'-220') [V-Kappa (Homo Sapiens Igkv4-1*01 (88.1%) -Igkj4*01 (90.9%), Cdr-Imgt [12.3.9] (27-38.56-58.95-103)) (1'-113') -Homo Sapiens Igkc*01 (100%), Km3, A45.1 (159), V101 (197) (114'- 220')]; Dimer(230-230'':233-233'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1, Glycoform Alfa
Cutaneous Melanoma
Aulos Bioscience, Inc.
P1/2
CC
(45)
Immunoglobulin H-Gamma1_L-Kappa, Anti-[Homo Sapiens Cd47 (Cd47 Molecule, Integrin Associated Protein, Iap, Mer6, Oa3) And Anti-[Homo Sapiens Dll3 (Delta-Like Ligand 3, Delta Like Canonical Notch Ligand 3)], Bispecific;
Neuroendocrine Carcinoma
Phanes Therapeutics
P1/2
CC
(45)
imp1734
Cancer
Eikon Therapeutics
P1/2
CC
(45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Hepatocellular Carcinoma
Zhejiang University
P1/2
CC
(45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Malignant Pancreatic Neoplasm
Zhejiang University
P1/2
CC
(45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Pancreatic Adenocarcinoma
Zhejiang University
P1/2
CC
(45)
Inobrodib
Peripheral T-Cell Lymphoma, Not Otherwise Specified
CellCentric Ltd.
P1/2
CC
(45)
Inqovi
Myelodysplastic Syndrome
National Cancer Institute (NCI)
P1/2
CC
(45)
Interferon Alpha-2
Breast Cancer
Roswell Park Cancer Institute
P1/2
CC
(45)
Interferon Alpha-2
Triple-Negative Breast Carcinoma
Roswell Park Cancer Institute
P1/2
CC
(45)
INX315
Her2-Receptor Negative Breast Cancer
Incyclix Bio
P1/2
CC
(45)
Isb 1442
Plasma Cell Myeloma
Ichnos Sciences SA
P1/2
CC
(45)
Showing 3626 to 3650 of 6,299 assets
Previous
Page 146 of 252
Next
